Shanmugam Muthusamy's Form 4 filing
Ani Pharmaceuticals Inc (ANIP) · filed May 21, 2024
- Accession no.
- 0001870913-24-000020
- Filed
- May 21, 2024
- Trade date
- May 20, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction. Open-market sales total $794.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Shanmugam MuthusamyCIK 0001870913 | Director, Officer (HEAD OF R&D, COO-NOVITIUM OPS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | Common Stock | SSaleDisposed | −12,855 | $61.81F2 | −$794,567.55 | 732,620 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The shares were sold in multiple trades at prices ranging from $61.44 to $62.36. The price reported above reflects the weighted average sales price.
Referenced by the price of 1 transaction in Table I.